Synta Pharmaceuticals Announces Key Senior Additions to Business and Scientific Teams Print This Story
[The brain drain at Millennium continues. It is natural, that some individuals are leaving when a company is donwsizing, but it has been a fairly steady trickle out of MLNM for quite some time now.
Terifay appears to have been a qualified person and it is difficult to see any obvious reason why he should leave. Apart from belonging to the Cor wing].
- Appoints Robert Terifay, Senior Vice President, Commercial Development and Strategy and Additional Senior Executives -
LEXINGTON, Mass., April 8 /PRNewswire/ -- Synta Pharmaceuticals Corp., a product-focused biopharmaceutical company, today announced the appointment of Robert Terifay as Senior Vice President, Commercial Development and Strategy
Robert Terifay, Senior Vice President, Commercial Development and Strategy. Mr. Terifay joins Synta from Millennium Pharmaceuticals Inc., where he was Senior Vice President, Oncology Marketing and Sales and Corporate Commercial Services. In this position, he managed the marketing strategy and sales
infrastructure that successfully launched Velcade(R) (bortezomib), a novel proteasome inhibitor for the treatment of multiple myeloma. At Millennium, Mr. Terifay contributed to the assessment of the market potential of early-stage research and development compounds and programs to determine long-term
development, clinical, and marketing strategies for viable product candidates.
As a company spokesperson for the financial community, Mr. Terifay provided the commercial perspective at securities analysts and earnings announcement presentations. Previously, Mr. Terifay was a Vice President at COR Therapeutics, which was acquired by Millennium in early 2002. In this capacity, he was responsible for successfully establishing the company's commercial presence in the acute care cardiovascular market.
Under his management, the company's lead compound, Integrilin(R) (eptifibatide), achieved and sustained a number one market share position. Prior to working at COR, Mr. Terifay held positions at Klemtner Advertising, G.D. Searle &
Company, and Schering Laboratories. Mr. Terifay holds a Masters of Management degree in Marketing and Health Service Management from the J.L. Kellogg Graduate School of Management at Northwestern University and earned his B.S. in Preprofessional Studies (Biology and Chemistry) at the University of Notre Dame in Indiana. |
